Predictors of Pharmacotherapy for Tobacco Use Among Veterans Admitted for COPD: The Role of Disparities and Tobacco Control Processes

Journal of General Internal Medicine

Volumn 31, Issue 6, 2016, Pages 623-629

  Melzer, Anne C ^a,b   Feemster, Laura C ^a,b   Collins, Margaret P ^b   Au, David H ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

COPD; disparities; nicotine replacement; pharmacotherapy; processes of care; smoking; tobacco

Indexed keywords

AMFEBUTAMONE; NICOTINE PATCH; STEROID; VARENICLINE; NICOTINE GUM;

ADULT; AGED; ARTICLE; BLACK PERSON; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; FEMALE; HEALTH DISPARITY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; HYPERTENSION; ICD-9; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOTHERAPY; NICOTINE REPLACEMENT THERAPY; PATIENT COUNSELING; PREDICTOR VARIABLE; PSYCHOSIS; SCORING SYSTEM; SMOKING CESSATION; TOBACCO USE; COMPLICATION; HEALTH CARE DISPARITY; HOSPITALIZATION; PROCEDURES; SENSITIVITY AND SPECIFICITY; SMOKING; STATISTICS AND NUMERICAL DATA; TOBACCO DEPENDENCE; UNITED STATES; UTILIZATION; VERY ELDERLY; VETERAN;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEALTHCARE DISPARITIES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PATIENT DISCHARGE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SENSITIVITY AND SPECIFICITY; SMOKING; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER; UNITED STATES; VETERANS;

EID: 84959104519     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-016-3623-4     Document Type: Article

References (53)

1. Murphy SL, Xu JU, Kochanek KD. Deaths: Final data for 2010. Hyattsville: National Center for Health Statistics; 2013.
2. Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: The lung health study. JAMA. 1994;272:1497–505.
3. Garcia-Aymerich J, Barreiro E, Farrero E, Marrades R, Morera J, Anto J. Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study). Eur Respir J. 2000;16:1037–42.
4. Yip NH, Yuen G, Lazar EJ, et al. Analysis of Hospitalizations for COPD Exacerbation: Opportunities for Improving Care. COPD: J Chron Obstructive Pulm Dis. 2010;7:85–92.
5. Emmons KM, Goldstein MG. Smokers who are hospitalized: a window of opportunity for cessation interventions. Prev Med. 1992;21:262–9.
6. Freund M, Campbell E, Paul C, et al. Smoking care provision in hospitals: a review of prevalence. Nicotine Tob Res Off J Soc Res Nicotine Tob. 2008;10:757–74.
7. Sonel AF, Good CB, Mulgund J, et al. Racial variations in treatment and outcomes of black and white patients with high-risk non-ST-elevation acute coronary syndromes: insights from CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines?). Circulation. 2005;111:1225–32.
8. Moolchan ET, Fagan P, Fernander AF, et al. Addressing tobacco-related health disparities. Addict (Abingdon, Engl) 2007;102 Suppl 2:30–42.
9. Cokkinides VE, Halpern MT, Barbeau EM, Ward E, Thun MJ. Racial and Ethnic Disparities in Smoking-Cessation Interventions: Analysis of the 2005 National Health Interview Survey. Am J Prev Med. 2008;34:404–12.
10. Fu SS, Sherman SE, Yano EM, van Ryn M, Lanto AB, Joseph AM. Ethnic disparities in the use of nicotine replacement therapy for smoking cessation in an equal access health care system. Am J Health Promot. 2005;20:108–16.
11. Eisner MD, Blanc PD, Omachi TA, et al. Socioeconomic status, race and COPD health outcomes. J Epidemiol Commun Health.2009.
12. Collins BF, Ramenofsky D, Au DH, Ma J, Uman JE, Feemster LC. The association of weight with the detection of airflow obstruction and inhaled treatment among patients with a clinical diagnosis of COPD. Chest 2014.
13. Herrin MA, Feemster LC, Crothers K, Uman JE, Bryson CL, Au DH. Combination antihypertensive therapy among patients with COPD. Chest. 2013;143:1312–20.
14. Melzer AC, Feemster LM, Uman JE, Ramenofsky DH, Au DH. Missing potential opportunities to reduce repeat COPD exacerbations. J Gen Intern Med. 2013;28:652–9.
15. McGinnis KA, Brandt CA, Skanderson M, et al. Validating smoking data from the Veteran's Affairs Health Factors dataset, an electronic data source. Nicotine Tob Res Off J Soc Res Nicotine Tob. 2011;13:1233–9.
16. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8–27.
17. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–9.
18. Hosmer JDW, Lemeshow S, Sturdivant RX. Model-Building Strategies and Methods for Logistic Regression. Applied Logistic Regression: John Wiley & Sons, Inc.; 2013:89–151
19. Rigotti NA, Clair C, Munafo MR, Stead LF. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev 2012;16.
20. Emmons KM, Goldstein MG, Roberts M, et al. The use of nicotine replacement therapy during hospitalization. Ann Behav Med: a Publ Soc Behav Med. 2000;22:325–9.
21. Faseru B, Turner M, Casey G, et al. Evaluation of a hospital-based tobacco treatment service: outcomes and lessons learned. J Hosp Med: an Off Publ Soci Hosp Med. 2011;6:211–8.
22. Jiménez-Ruiz CA, Masa F, Miravitlles M, et al. Smoking characteristics*: Differences in attitudes and dependence between healthy smokers and smokers with COPD. CHEST J. 2001;119:1365–70.
23. Vozoris NT, Stanbrook MB. Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma. Respir Med. 2011;105:477–84.
24. Morrell HER, Cohen LM, al'Absi M. Physiological and psychological symptoms and predictors in early nicotine withdrawal. Pharmacol Biochem Behav. 2008;89:272–8.
25. Rigotti NA, Arnsten JH, McKool KM, Wood-Reid KM, Pasternak RC, Singer DE. Smoking by Patients in a Smoke-Free Hospital: Prevalence, Predictors, and Implications. Prev Med. 2000;31:159–66.
26. Regan S, Reyen M, Richards AE, Lockhart AC, Liebman AK, Rigotti NA. Nicotine Replacement Therapy Use at Home After Use During a Hospitalization. Nicotine Tob Res. 2012;14:885–9.
27. Stevens VJ, Glasgow RE, Hollis JF, Mount K. Implementation and Effectiveness of a Brief Smoking-Cessation Intervention for Hospital Patients. Med Care. 2000;38:451–9.
28. Reeves GR, Wang TY, Reid KJ, et al. Dissociation between hospital performance of the smoking cessation counseling quality metric and cessation outcomes after myocardial infarction. Arch Intern Med. 2008;168:2111–7.
29. Fiore MC, Jaen CR, Baker TB, Baily WC, Benowitz NL, Curry SJ, et al. Treating Tobacco Use and Dependence: 2008 Update. U.S. Department of Health and Human Services. Public Health Service; Rockville, MD: 2008.
30. Sciamanna CN, Hoch JS, Duke GC, Fogle MN, Ford DE. Comparison of Five Measures of Motivation to Quit Smoking Among a Sample of Hospitalized Smokers. J Gen Intern Med. 2000;15:16–23.
31. Lopez-Quintero C, Crum RM, Neumark YD. Racial/Ethnic Disparities in Report of Physician-Provided Smoking Cessation Advice: Analysis of the 2000 National Health Interview Survey. Am J Public Health. 2006;96:2235–9.
32. Trinidad DR, Perez-Stable EJ, White MM, Emery SL, Messer K. A nationwide analysis of US racial/ethnic disparities in smoking behaviors, smoking cessation, and cessation-related factors. Am J Public Health. 2011;101:699–706.
33. Doescher MP, Saver BG. Physicians' advice to quit smoking. The glass remains half empty. J Fam Pract. 2000;49:543–7.
34. Steinberg MB, Akincigil A, Delnevo CD, Crystal S, Carson JL. Gender and Age Disparities for Smoking-Cessation Treatment. Am J Prev Med. 2006;30:405–12.
35. Houston TK, Scarinci IC, Person SD, Greene PG. Patient smoking cessation advice by health care providers: the role of ethnicity, socioeconomic status, and health. Am J Public Health. 2005;95:1056–61.
36. Blair IV, Steiner JF, Fairclough DL, et al. Clinicians’ implicit ethnic/racial bias and perceptions of care among Black and Latino patients. Ann Fam Med. 2013;11:43–52.
37. McRobbie H, Hajek P. Nicotine replacement therapy in patients with cardiovascular disease: guidelines for health professionals. Addict (Abingdon, Engl). 2001;96:1547–51.
38. Joseph AM, Norman SM, Ferry LH, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med. 1996;335:1792–8.
39. Bansal MA, Cummings KM, Hyland A, Giovino GA. Stop-smoking medications: who uses them, who misuses them, and who is misinformed about them? Nicotine Tob Res Off J Soc Res Nicotine Tob. 2004;6(Suppl 3):S303–10.
40. Shiffman S, Ferguson SG, Rohay J, Gitchell JG. Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: relationship with use and compliance. Addict (Abingdon, Engl). 2008;103:1371–8.
41. Wilson JS, Elborn JS, Fitzsimons D. ‘It’s not worth stopping now’: why do smokers with chronic obstructive pulmonary disease continue to smoke? A qualitative study. J Clin Nurs. 2011;20:819–27.
42. Lasser K, Boyd J, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: A population-based prevalence study. JAMA. 2000;284:2606–10.
43. Kupiainen H, Kinnula VL, Lindqvist A, et al. Successful smoking cessation in COPD: association with comorbidities and mortality. Pulm Med. 2012;2012:725024.
44. Prochaska JJ, Fletcher L, Hall SE, Hall SM. Return to smoking following a smoke-free psychiatric hospitalization. Am J Addict. 2006;15:15–22.
45. Prochaska JJ. Smoking and mental illness—breaking the link. N Engl J Med. 2011;365:196–8.
46. Studts JL, Ghate SR, Gill JL, et al. Validity of Self-reported Smoking Status among Participants in a Lung Cancer Screening Trial. Cancer Epidemiol Biomark Prev. 2006;15:1825–8.
47. Yeager DS, Krosnick JA. The validity of self-reported nicotine product use in the 2001–2008 National Health and Nutrition Examination Survey. Med Care. 2010;48:1128–32.
48. Shen YH, A. Zhang, S. Kazis, L. VHA Enrollees' Health Care Coverage and Use of Care. Med Care Res Rev 2003;60.
49. Sherman SE, Fu SS, Joseph AM, Lanto AB, Yano EM. Gender differences in smoking cessation services received among veterans. Womens Health Issues. 2005;15:126–33.
50. Lawrence D, Mitrou F, Zubrick SR. Smoking and mental illness: results from population surveys in Australia and the United States. BMC Public Health. 2009;9:285.
51. Control CfD, Prevention. Vital signs: current cigarette smoking among adults aged ≥ 18 years with mental illness-United States, 2009–2011. MMWR Morbidity and mortality weekly report 2013;62:81.
52. Himelhoch S, Lehman A, Kreyenbuhl J, Daumit G, Brown C, Dixon L. Prevalence of chronic obstructive pulmonary disease among those with serious mental illness. Am J Psychiatry. 2004;161:2317–9.
53. Sokal J, Messias E, Dickerson FB, et al. Comorbidity of medical illnesses among adults with serious mental illness who are receiving community psychiatric services. J Nerv Ment Dis. 2004;192:421–7.